Role of Semaphorin 3A in Kidney Development and Diseases

被引:2
|
作者
Sang, Yizhen [1 ,2 ]
Tsuji, Kenji [1 ]
Nakanoh, Hiroyuki [1 ]
Fukushima, Kazuhiko [1 ,3 ,4 ]
Kitamura, Shinji [1 ,5 ]
Wada, Jun [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, 2-5-1 Shikata Cho, Okayama 7008558, Japan
[2] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Rheumatol & Immunol, Shanghai 200072, Peoples R China
[3] Massachusetts Gen Hosp, Ctr Syst Biol, Dept Med, Program Membrane Biol,Div Nephrol, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA 02114 USA
[5] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nursing Sci, Okayama 7191197, Japan
关键词
semaphorin; 3A; neuropilin-1; podocyte; diabetic nephropathy; acute kidney injury; chronic kidney injury; lupus nephritis; fibrosis; apoptosis; inflammation; PODOCYTE SHAPE; GUIDANCE CUE; INJURY; INFLAMMATION; BIOMARKERS; EXPRESSION; PREDICTS; PROMOTES; PROTEIN; PLEXINS;
D O I
10.3390/diagnostics13193038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kidney diseases are worldwide public health problems affecting millions of people. However, there are still limited therapeutic options against kidney diseases. Semaphorin 3A (SEMA3A) is a secreted and membrane-associated protein, which regulates diverse functions, including immune regulation, cell survival, migration and angiogenesis, thus involving in the several pathogeneses of diseases, including eyes and neurons, as well as kidneys. SEMA3A is expressed in podocytes and tubular cells in the normal adult kidney, and recent evidence has revealed that excess SEMA3A expression and the subsequent signaling pathway aggravate kidney injury in a variety of kidney diseases, including nephrotic syndrome, diabetic nephropathy, acute kidney injury, and chronic kidney disease. In addition, several reports have demonstrated that the inhibition of SEMA3A ameliorated kidney injury via a reduction in cell apoptosis, fibrosis and inflammation; thus, SEMA3A may be a potential therapeutic target for kidney diseases. In this review article, we summarized the current knowledge regarding the role of SEMA3A in kidney pathophysiology and their potential use in kidney diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Semaphorin 3A is a chemoattractant for cortical apical dendrites
    Franck Polleux
    Theresa Morrow
    Anirvan Ghosh
    Nature, 2000, 404 : 567 - 573
  • [32] SOLUBLE SEMAPHORIN 3A REGULATES THE IMMUNE RESPONSE
    Schlahsa, Laura
    Zenk, Jana
    Aufderbeck, Susanne
    Figueiredo, Constanca
    Blasczyk, Rainer
    HUMAN IMMUNOLOGY, 2009, 70 : S157 - S157
  • [33] Semaphorin 3A Expression in the Colon of Hirschsprung Disease
    Wang, Li-Li
    Fan, Yang
    Zhou, Feng-hua
    Li, Hui
    Zhang, Yi
    Miao, Jia-Ning
    Gu, Hui
    Huang, Tian-Chu
    Yuan, Zheng-Wei
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2011, 91 (09) : 842 - 847
  • [34] Inhibition of CNS Remyelination by the Presence of Semaphorin 3A
    Syed, Yasir A.
    Hand, Elisabeth
    Moebius, Wiebke
    Zhao, Chao
    Hofer, Matthias
    Nave, Klaus A.
    Kotter, Mark R.
    JOURNAL OF NEUROSCIENCE, 2011, 31 (10): : 3719 - 3728
  • [35] SEMAPHORIN 3A AS A POSSIBLE IMMUNOREGULATOR IN SYSTEMIC SCLEROSIS
    Rimar, D.
    Rosner, I.
    Slobodin, G.
    Rozenbaum, M.
    Halasz, K.
    Haj, T.
    Jiries, N.
    Kaly, L.
    Boulman, N.
    Daood, R.
    Vadas, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S66 - S66
  • [36] Semaphorin 3A: Is a key player in the pathogenesis of asthma
    Cozacov, Ronen
    Halasz, Katlin
    Haj, Tharwat
    Vadasz, Zahava
    CLINICAL IMMUNOLOGY, 2017, 184 : 70 - 72
  • [37] Overexpression of semaphorin 3A in patients with urothelial cancer
    Vadasz, Zahava
    Rubinstein, Jacob
    Bejar, Jacob
    Sheffer, Huila
    Halachmi, Sarel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (04) : 161.e1 - 161.e6
  • [38] SEMAPHORIN 3A AS A POSSIBLE IMMUNOREGULATOR IN SYSTEMIC SCLEROSIS
    Rimer, D.
    Rosner, I.
    Slobodin, G.
    Boulman, N.
    Rozenbaum, M.
    Halasz, K.
    Haj, T.
    Jiries, N.
    Kaly, L.
    Vadasz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 868 - 868
  • [39] Inhibition of pathological retinal neovascularization by semaphorin 3A
    Yu, Wenzhen
    Bai, Yujing
    Han, Na
    Wang, Fei
    Zhao, Min
    Huang, Lvzhen
    Li, Xiaoxin
    MOLECULAR VISION, 2013, 19 : 1397 - 1405
  • [40] Regulation of dendritic length and branching by semaphorin 3A
    Fenstermaker, V
    Chen, YC
    Ghosh, A
    Yuste, R
    JOURNAL OF NEUROBIOLOGY, 2004, 58 (03): : 403 - 412